Ron Squarer, CEO at ARRAY BIOPHARMA INC (ARRY), sold 64,954 shares at $8.25 ($529K) on 2015-03-02, disclosed to the SEC on 2015-03-04.
Open-market sale of $529k ARRY by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.96 | 24,954 | $199K | 37.6% |
| 2 | $8.25 | 40,000 | $330K | 62.4% |
| Total | $8.14 avg | 64,954 | $529K | 100% |
| Filing → |
| ARRY | SELL | 2019-02-01 | $6.0M | — | Filing → |
| ARRY | SELL | 2018-06-29 | $6.6M | — | Filing → |
| ARRY | SELL | 2017-12-19 | $8.9M | — | Filing → |